As a Director of Diagnostics at Global Health Labs (GH Labs), Anne-Laure Le Ny leads a team developing assays and diagnostics using molecular biology, biochemistry, and microfluidics techniques to strengthen the detection of infectious agents, bacterial contaminants, and parasitic eggs by healthcare providers in low- and middle-income countries.

Prior to GH Labs, Anne-Laure was a Principal Investigator, and before that, senior research scientist at Global Good, an investment fund of Intellectual Ventures. Anne-Laure began her career at Abraxis BioScience and later worked at the Institute for Advanced Health (Nantworks Group), where she helped develop assays to support novel immunotherapeutics and drug discovery targeting cancer and infectious diseases.

Anne-Laure earned her PhD and MS in Chemical Engineering from the University of Southern California and BS in Applied Chemistry from the University of Orléans, France.